Literature DB >> 21492250

Toll-like receptors and skin.

A T Ermertcan1, F Öztürk, K Gündüz.   

Abstract

Toll-like receptors are important pattern recognition receptors which have key roles in both innate and adaptive immune responses. They are strongly associated with the pathogenesis of inflammatory and autoimmune diseases. Furthermore, Toll-like receptors have also been implicated in the pathogenesis of several skin diseases such as skin infections, psoriasis, acne vulgaris, lichen planus, Behçet's disease, leprosy, syphilis, Lyme disease, atopic dermatitis and allergic contact dermatitis, mycosis fungoides, non-melanoma skin cancers and melanoma. In this manuscript, the structure and functions of Toll-like receptors in immune responses, their impact on skin diseases and recent advances on therapeutic usage have been reviewed.
© 2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21492250     DOI: 10.1111/j.1468-3083.2011.04049.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  13 in total

1.  Interferon-Gamma Enhances TLR3 Expression and Anti-Viral Activity in Keratinocytes.

Authors:  A I Kajita; Shin Morizane; Tetsuya Takiguchi; Takenobu Yamamoto; Masao Yamada; Keiji Iwatsuki
Journal:  J Invest Dermatol       Date:  2015-03-30       Impact factor: 8.551

2.  TLR7 Gln11Leu single nucleotide polymorphism and susceptibility to cutaneous melanoma.

Authors:  Lisa Elefanti; Giorgia Sacco; Camilla Stagni; Marco Rastrelli; Chiara Menin; Irene Russo; Mauro Alaibac
Journal:  Oncol Lett       Date:  2016-05-16       Impact factor: 2.967

3.  Association between Toll-like receptor 7 Gln11Leu single-nucleotide polymorphism and basal cell carcinoma.

Authors:  Irene Russo; Camilla Cona; Andrea Saponeri; Franco Bassetto; Vincenzo Baldo; Mauro Alaibac
Journal:  Biomed Rep       Date:  2016-02-15

4.  Toll-like receptors (TLR) 2 and 4 expression of keratinocytes from patients with localized and disseminated dermatophytosis.

Authors:  Cristiane Beatriz de Oliveira; Cídia Vasconcellos; Neusa Y Sakai-Valente; Mirian Nacagami Sotto; Fernanda Guedes Luiz; Walter Belda Júnior; Maria da Gloria Teixeira de Sousa; Gil Benard; Paulo Ricardo Criado
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jan-Feb       Impact factor: 1.846

5.  TLR7-expressing cells comprise an interfollicular epidermal stem cell population in murine epidermis.

Authors:  Chaoran Yin; Ting Zhang; Liangjun Qiao; Jia Du; Shuang Li; Hengguang Zhao; Fangfang Wang; Qiaorong Huang; Wentong Meng; Hongyan Zhu; Hong Bu; Hui Li; Hong Xu; Xianming Mo
Journal:  Sci Rep       Date:  2014-07-25       Impact factor: 4.379

Review 6.  The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis.

Authors:  Lixiang Sun; Wenjie Liu; Ling-Juan Zhang
Journal:  J Immunol Res       Date:  2019-11-14       Impact factor: 4.818

Review 7.  Melanogenesis Connection with Innate Immunity and Toll-Like Receptors.

Authors:  Saaya Koike; Kenshi Yamasaki
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

8.  Toll-like receptor 4 contributes to chronic itch, alloknesis, and spinal astrocyte activation in male mice.

Authors:  Tong Liu; Qingjian Han; Gang Chen; Ya Huang; Lin-Xia Zhao; Temugin Berta; Yong-Jing Gao; Ru-Rong Ji
Journal:  Pain       Date:  2016-04       Impact factor: 7.926

Review 9.  Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin.

Authors:  Yanyun Jiang; Lam C Tsoi; Allison C Billi; Nicole L Ward; Paul W Harms; Chang Zeng; Emanual Maverakis; J Michelle Kahlenberg; Johann E Gudjonsson
Journal:  JCI Insight       Date:  2020-10-15

Review 10.  Gut Microbiota, Probiotics, and Their Interactions in Prevention and Treatment of Atopic Dermatitis: A Review.

Authors:  Zhifeng Fang; Lingzhi Li; Hao Zhang; Jianxin Zhao; Wenwei Lu; Wei Chen
Journal:  Front Immunol       Date:  2021-07-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.